SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-21-021019
Filing Date
2021-08-23
Accepted
2021-08-23 16:47:11
Documents
6
Effectiveness Date
2021-08-23

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 101514
2 ex5-1.htm EX-5.1 10454
3 ex23-1.htm EX-23.1 3602
4 ex23-2.htm EX-23.2 4620
5 ex99-1.htm EX-99.1 62264
6 ex5-1_001.jpg GRAPHIC 2661
  Complete submission text file 0001493152-21-021019.txt   187353
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-259009 | Film No.: 211197510
SIC: 2834 Pharmaceutical Preparations